Concepedia

Vector Biosafety

Vector Biosafety is a biosafety framework that specifies the design, containment, and risk mitigation strategies for gene delivery vectors to ensure their safe use in therapeutic applications while minimizing unintended biological consequences.

24

Publications

1.2K

Citations

130

Authors

51

Institutions

Publications per year

2017–2026

4

Parents

Publications

24

Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

Hasan Rehman, Ann W. Silk, Michael P. Kane et al. · Journal for ImmunoTherapy of Cancer · 2016 · 366 citations · Full text

, , +17

Lentiviral vectors pseudotyped with murine ecotropic envelope: Increased biosafety and convenience in preclinical research

Axel Schambach, Melanie Galla, Ute Modlich et al. · Experimental Hematology · 2006 · 108 citations

, , +14

Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver

Ali Nowrouzi, Magalie Penaud‐Budloo, Christine Kaeppel et al. · Molecular Therapy · 2012 · 104 citations · Full text

, , +14

Progress in arginine-based gene delivery systems

Yang Zhou, Shuyan Han, Zhiqing Liang et al. · Journal of Materials Chemistry B · 2020 · 63 citations

, , +17

Bioinformatic Clonality Analysis of Next-Generation Sequencing-Derived Viral Vector Integration Sites

Anne I.J. Arens, Jens-Uwe Appelt, Cynthia C. Bartholomae et al. · Human Gene Therapy Methods · 2012 · 45 citations · Full text

, , +13

1–5 of 24

Authors

130

  1. CV
    Christof von Kalle

    National Center for Tumor Diseases, Germany

    5 publications · 314 citations

    5

    h-index

  2. MS
    Manfred Schmidt

    National Center for Tumor Diseases, Germany

    3 publications · 183 citations

    3

    h-index

  3. AI
    Anne I.J. Arens

    Radboud University Nijmegen, Netherlands

    2 publications · 68 citations

    2

    h-index

  4. KL
    Kenneth Lundström

    University of South Florida, United States

    2 publications · 52 citations

    2

    h-index

  5. AP
    Anna Paruzynski

    Heidelberg University, Germany

    2 publications · 68 citations

    2

    h-index

1–5 of 130

Institutions

51

  1. National Center for Tumor Diseases

    Heidelberg, Germany

    5 h-index

    25 publications

    1.3K citations

  2. Heidelberg University

    Heidelberg, Germany

    3 h-index

    20 publications

    1.1K citations

  3. German Cancer Research Center

    Heidelberg, Germany

    3 h-index

    20 publications

    1.1K citations

  4. Kantonsschule Enge

    Zurich, Switzerland

    2 h-index

    2 publications

    52 citations

  5. Medizinische Hochschule Hannover

    Hanover, Germany

    2 h-index

    15 publications

    674 citations

  6. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    2 h-index

    3 publications

    109 citations

  7. Cincinnati Children's Hospital Medical Center

    Cincinnati, United States

    2 h-index

    2 publications

    131 citations

  8. GlaxoSmithKline (United States)

    Philadelphia, United States

    1 h-index

    2 publications

    56 citations

1–8 of 51

Venues

  1. PubMed

    Repository · 4 publications · 132 citations

    4

    h-index

  2. Molecular Therapy

    3 publications · 161 citations

    3

    h-index

  3. Applied Biosafety

    APB · 2 publications · 40 citations

    2

    h-index

  4. Current Protocols in Neuroscience

    2 publications · 52 citations

    2

    h-index

  5. Gene Therapy

    1 publications · 22 citations

    1

    h-index

1–5